Cargando…

Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease

PURPOSE: Parkinson disease (PD) is a progressive neurodegenerative disorder in which dopaminergic (DAergic) systems are destroyed (particularly in the nigrostriatal system), causing both motor and nonmotor symptoms. Hippocampal neuroplasticity is altered in PD animal models, resulting in nonmotor dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bohye, Weerasinghe-Mudiyanselage, Poornima D. E., Ang, Mary Jasmin, Lee, Jeongmin, Kang, Sohi, Kim, Jong-Choon, Kim, Sung-Ho, Kim, Joong-Sun, Jung, Chaeyong, Shin, Taekyun, Moon, Changjong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767684/
https://www.ncbi.nlm.nih.gov/pubmed/36503212
http://dx.doi.org/10.5213/inj.2244252.126
_version_ 1784854013066346496
author Kim, Bohye
Weerasinghe-Mudiyanselage, Poornima D. E.
Ang, Mary Jasmin
Lee, Jeongmin
Kang, Sohi
Kim, Jong-Choon
Kim, Sung-Ho
Kim, Joong-Sun
Jung, Chaeyong
Shin, Taekyun
Moon, Changjong
author_facet Kim, Bohye
Weerasinghe-Mudiyanselage, Poornima D. E.
Ang, Mary Jasmin
Lee, Jeongmin
Kang, Sohi
Kim, Jong-Choon
Kim, Sung-Ho
Kim, Joong-Sun
Jung, Chaeyong
Shin, Taekyun
Moon, Changjong
author_sort Kim, Bohye
collection PubMed
description PURPOSE: Parkinson disease (PD) is a progressive neurodegenerative disorder in which dopaminergic (DAergic) systems are destroyed (particularly in the nigrostriatal system), causing both motor and nonmotor symptoms. Hippocampal neuroplasticity is altered in PD animal models, resulting in nonmotor dysfunctions. However, little is known about the precise mechanism underlying the hippocampal dysfunctions in PD. METHODS: Striatal 6-hydroxydopamine (6-OHDA) infusions were performed unilaterally in adult Sprague Dawley rats. Both motor and nonmotor symptoms alongside the expression of tyrosine hydroxylase (TH) in the substantia nigra and striatum were confirmed in 6-OHDA-lesioned rats. The neuronal architecture in the hippocampus was analyzed by Golgi staining. RESULTS: During the 7–8 weeks after infusion, the 6-OHDA-lesioned rats exhibited motor and nonmotor dysfunctions (especially anxiety/depression-like behaviors). Rats with unilateral 6-OHDA infusion displayed reduced TH+ immunoreactivity in the ipsilateral nigrostriatal pathway of the brain. Golgi staining revealed that striatal 6-OHDA infusion significantly decreased the dendritic complexity (i.e., number of crossing dendrites, total dendritic length, and branch points) in the ipsilateral hippocampal conus ammonis 1 (CA1) apical/basal and dentate gyrus (DG) subregions. Additionally, the dendritic spine density and morphology were significantly altered in the CA1 apical/basal and DG subregions following striatal 6-OHDA infusion. However, alteration of microglial and astrocytic distributions did not occur in the hippocampus following striatal 6-OHDA infusion. CONCLUSIONS: The present study provides anatomical evidence that the structural plasticity in the hippocampus is altered in the late phase following striatal 6-OHDA infusion in rats, possibly as a result of the prolonged suppression of the DAergic system, and independent of neuroinflammation.
format Online
Article
Text
id pubmed-9767684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Continence Society
record_format MEDLINE/PubMed
spelling pubmed-97676842023-01-04 Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease Kim, Bohye Weerasinghe-Mudiyanselage, Poornima D. E. Ang, Mary Jasmin Lee, Jeongmin Kang, Sohi Kim, Jong-Choon Kim, Sung-Ho Kim, Joong-Sun Jung, Chaeyong Shin, Taekyun Moon, Changjong Int Neurourol J Original Article PURPOSE: Parkinson disease (PD) is a progressive neurodegenerative disorder in which dopaminergic (DAergic) systems are destroyed (particularly in the nigrostriatal system), causing both motor and nonmotor symptoms. Hippocampal neuroplasticity is altered in PD animal models, resulting in nonmotor dysfunctions. However, little is known about the precise mechanism underlying the hippocampal dysfunctions in PD. METHODS: Striatal 6-hydroxydopamine (6-OHDA) infusions were performed unilaterally in adult Sprague Dawley rats. Both motor and nonmotor symptoms alongside the expression of tyrosine hydroxylase (TH) in the substantia nigra and striatum were confirmed in 6-OHDA-lesioned rats. The neuronal architecture in the hippocampus was analyzed by Golgi staining. RESULTS: During the 7–8 weeks after infusion, the 6-OHDA-lesioned rats exhibited motor and nonmotor dysfunctions (especially anxiety/depression-like behaviors). Rats with unilateral 6-OHDA infusion displayed reduced TH+ immunoreactivity in the ipsilateral nigrostriatal pathway of the brain. Golgi staining revealed that striatal 6-OHDA infusion significantly decreased the dendritic complexity (i.e., number of crossing dendrites, total dendritic length, and branch points) in the ipsilateral hippocampal conus ammonis 1 (CA1) apical/basal and dentate gyrus (DG) subregions. Additionally, the dendritic spine density and morphology were significantly altered in the CA1 apical/basal and DG subregions following striatal 6-OHDA infusion. However, alteration of microglial and astrocytic distributions did not occur in the hippocampus following striatal 6-OHDA infusion. CONCLUSIONS: The present study provides anatomical evidence that the structural plasticity in the hippocampus is altered in the late phase following striatal 6-OHDA infusion in rats, possibly as a result of the prolonged suppression of the DAergic system, and independent of neuroinflammation. Korean Continence Society 2022-11 2022-11-30 /pmc/articles/PMC9767684/ /pubmed/36503212 http://dx.doi.org/10.5213/inj.2244252.126 Text en Copyright © 2022 Korean Continence Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Bohye
Weerasinghe-Mudiyanselage, Poornima D. E.
Ang, Mary Jasmin
Lee, Jeongmin
Kang, Sohi
Kim, Jong-Choon
Kim, Sung-Ho
Kim, Joong-Sun
Jung, Chaeyong
Shin, Taekyun
Moon, Changjong
Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
title Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
title_full Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
title_fullStr Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
title_full_unstemmed Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
title_short Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
title_sort changes in the neuronal architecture of the hippocampus in a 6-hydroxydopamine-lesioned rat model of parkinson disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767684/
https://www.ncbi.nlm.nih.gov/pubmed/36503212
http://dx.doi.org/10.5213/inj.2244252.126
work_keys_str_mv AT kimbohye changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT weerasinghemudiyanselagepoornimade changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT angmaryjasmin changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT leejeongmin changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT kangsohi changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT kimjongchoon changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT kimsungho changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT kimjoongsun changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT jungchaeyong changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT shintaekyun changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease
AT moonchangjong changesintheneuronalarchitectureofthehippocampusina6hydroxydopaminelesionedratmodelofparkinsondisease